J. Antoine, E. Prina, N. Courret, and T. Lang, Leishmania spp.: on the Interactions They Establish with Antigen-Presenting Cells of their Mammalian Hosts, Adv Parasitol, vol.58, pp.1-68, 2004.
DOI : 10.1016/S0065-308X(04)58001-6

C. De-oliveira, I. Nascimento, A. Barral, and M. Soto, Challenges and perspectives in vaccination against leishmaniasis, Parasitology International, vol.58, issue.4, pp.319-324, 2009.
DOI : 10.1016/j.parint.2009.07.013

J. Alvar, S. Croft, and P. Olliaro, Chemotherapy in the Treatment and Control of Leishmaniasis, Adv Parasitol, vol.61, pp.223-274, 2006.
DOI : 10.1016/S0065-308X(05)61006-8

F. Chappuis, S. Sundar, A. Hailu, H. Ghalib, and S. Rijal, Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?, Nature Reviews Microbiology, vol.14, issue.11, pp.873-882, 2007.
DOI : 10.1038/nrmicro1748

S. Croft, K. Seifert, and Y. V. , Current scenario of drug development for leishmaniasis, Indian J Med Res, vol.123, pp.399-410, 2006.

H. Murray, J. Berman, C. Davies, and N. Saravia, Advances in leishmaniasis, The Lancet, vol.366, issue.9496, pp.1561-1577, 2005.
DOI : 10.1016/S0140-6736(05)67629-5

K. Bleicher, H. Bohm, K. Muller, and A. Alanine, A guide to drug discovery: Hit and lead generation: beyond high-throughput screening, Nature Reviews Drug Discovery, vol.2, issue.5, pp.369-378, 2003.
DOI : 10.1038/nrd1086

S. St-george, J. Bishop, R. Titus, and C. Selitrennikoff, Novel Compounds Active against Leishmania major, Antimicrobial Agents and Chemotherapy, vol.50, issue.2, pp.474-479, 2006.
DOI : 10.1128/AAC.50.2.474-479.2006

O. Shimony and C. Jaffe, Rapid fluorescent assay for screening drugs on Leishmania amastigotes, Journal of Microbiological Methods, vol.75, issue.2, pp.196-200, 2008.
DOI : 10.1016/j.mimet.2008.05.026

E. Sharlow, D. Close, T. Shun, S. Leimgruber, and R. Reed, Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen, PLoS Neglected Tropical Diseases, vol.8, issue.11, p.540, 2009.
DOI : 10.1371/journal.pntd.0000540.s003

J. Siqueira-neto, O. Song, H. Oh, J. Sohn, and G. Yang, Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds, PLoS Neglected Tropical Diseases, vol.73, issue.5, p.675, 2010.
DOI : 10.1371/journal.pntd.0000675.s002

URL : https://hal.archives-ouvertes.fr/pasteur-00696809

P. Pescher, T. Blisnick, P. Bastin, and G. Spath, Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation, Cellular Microbiology, vol.48, issue.7, pp.978-991, 2011.
DOI : 10.1111/j.1462-5822.2011.01593.x

URL : https://hal.archives-ouvertes.fr/pasteur-01433560

A. Buades, B. Coll, and J. Morel, On image denoising methods, 2004.

A. Kuijper, On detecting all saddle points in 2D images, Pattern Recognition Letters, vol.25, issue.15, pp.1665-1672, 2004.
DOI : 10.1016/j.patrec.2004.06.017

K. Suzuki, I. Horiba, and N. Sugie, Linear-time connected-component labeling based on sequential local operations, Computer Vision and Image Understanding, vol.89, issue.1, pp.1-23, 2003.
DOI : 10.1016/S1077-3142(02)00030-9

J. Zhang, T. Chung, and K. Oldenburg, A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays, Journal of Biomolecular Screening, vol.4, issue.2, 1999.
DOI : 10.1177/108705719900400206

K. Seifert, P. Escobar, and S. Croft, In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent, Journal of Antimicrobial Chemotherapy, vol.65, issue.3, pp.508-511, 2010.
DOI : 10.1093/jac/dkp500

A. Gebre-hiwot, G. Tadesse, S. Croft, and D. Frommel, An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1, Acta Tropica, vol.51, issue.3-4, 1992.
DOI : 10.1016/0001-706X(92)90042-V

F. Delmas, D. Giorgio, C. Elias, R. Gasquet, M. Azas et al., Antileishmanial Activity of Three Saponins Isolated from Ivy, ??-Hederin, ??-Hederin and Hederacolchiside A1, as Compared to Their Action on Mammalian Cells Cultured in Vitro, Planta Medica, vol.66, issue.4, pp.343-347, 2000.
DOI : 10.1055/s-2000-8541

A. Mohamed, T. Taye, and H. Akuffo, Mechanisms of resistance toLeishmania aethiopica. I. Interferon-?? in combination with a cytokine (not tumor necrosis factor-??) is required, but cannot act alone in the inhibition of intracellular forms ofL. aethiopica in THP1 cells, European Journal of Immunology, vol.50, issue.9, pp.2331-2337, 1992.
DOI : 10.1002/eji.1830220923

R. Da-luz, M. Vermeersch, J. Dujardin, P. Cos, and L. Maes, In Vitro Sensitivity Testing of Leishmania Clinical Field Isolates: Preconditioning of Promastigotes Enhances Infectivity for Macrophage Host Cells, Antimicrobial Agents and Chemotherapy, vol.53, issue.12, pp.5197-5203, 2009.
DOI : 10.1128/AAC.00866-09

M. Vermeersch, R. Da-luz, K. Tote, J. Timmermans, and P. Cos, In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences, Antimicrobial Agents and Chemotherapy, vol.53, issue.9, pp.3855-3859, 2009.
DOI : 10.1128/AAC.00548-09

W. Van-blitterswijk and M. Verheij, Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects, Current Pharmaceutical Design, vol.14, issue.21, pp.2061-2074, 2008.
DOI : 10.2174/138161208785294636

S. Rijal, Y. V. Chappuis, F. Decuypere, S. Khanal, and B. , Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?, Microbes and Infection, vol.9, issue.4, pp.529-535, 2007.
DOI : 10.1016/j.micinf.2007.01.009

D. Payne, M. Gwynn, D. Holmes, and D. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery, Nature Reviews Drug Discovery, vol.293, issue.1, pp.29-40, 2007.
DOI : 10.1038/nrd2201

D. Sereno, C. Da-silva, A. Mathieu-daude, F. Ouaissi, and A. , Advances and perspectives in Leishmania cell based drug-screening procedures, Parasitology International, vol.56, issue.1, pp.3-7, 2007.
DOI : 10.1016/j.parint.2006.09.001

URL : https://hal.archives-ouvertes.fr/hal-00376733

A. Dube, R. Gupta, and N. Singh, Reporter genes facilitating discovery of drugs targeting protozoan parasites, Trends in Parasitology, vol.25, issue.9, pp.432-439, 2009.
DOI : 10.1016/j.pt.2009.06.006

F. Squina, A. Pedrosa, V. Nunes, A. Cruz, and L. Tosi, Shuttle mutagenesis and targeted disruption of a telomere-located essential gene of Leishmania, Parasitology, vol.114, issue.04, pp.511-522, 2007.
DOI : 10.1038/35071118

S. Pulido, D. Munoz, A. Restrepo, C. Mesa, and J. Alzate, Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs, Acta Tropica, vol.122, issue.1, 2011.
DOI : 10.1016/j.actatropica.2011.11.015

A. Bolhassani, T. Taheri, Y. Taslimi, S. Zamanilui, and F. Zahedifard, Fluorescent Leishmania species: Development of stable GFP expression and its application for in vitro and in vivo studies, Experimental Parasitology, vol.127, issue.3, pp.637-645, 2011.
DOI : 10.1016/j.exppara.2010.12.006

URL : https://hal.archives-ouvertes.fr/pasteur-00786977

J. De-toledo, J. Santos, A. Rodrigues-de-moura, T. Antoniazi, S. Brodskyn et al., Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo, Parasitology International, vol.58, issue.1, pp.45-50, 2009.
DOI : 10.1016/j.parint.2008.09.006

A. Carpenter, Image-based chemical screening, Nature Chemical Biology, vol.7, issue.8, pp.461-465, 2007.
DOI : 10.1038/nchembio.2007.15

D. Muylder, G. Ang, K. Chen, S. Arkin, M. Engel et al., A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit, PLoS Neglected Tropical Diseases, vol.129, issue.7, 2011.
DOI : 10.1371/journal.pntd.0001253.t001